A Georgia Tech study challenges a decades-old explanation for one of neuroscience's most famous signals, revealing an intrinsic neural code for tracking time.

The Georgia Tech researcher and longtime neuroscience community leader will help catalyze new collaborations and research opportunities across the Institute for Neuroscience, Neurotechnology, and Society (INNS).

A Georgia Tech student transformed her search to understand her mother's ALS into AI-driven research that could reshape how scientists study neurodegenerative diseases.

Georgia Tech researchers found that predatory bacteria can halt the spread of a destructive coral disease by hunting and consuming pathogens responsible for the infection.

Parker H. Petit’s commitment will launch a research hub focused on using artificial intelligence to model diseases, identify treatment paths, and move discoveries closer to patient care.

A running theme throughout the conference was the growing influence of cutting-edge technologies like artificial intelligence — and how researchers are preparing for the ethical, social and practical challenges that they bring.

The 2026 cohort includes 28 early-career scientists based in the United States who are changing the world with their work.

The research captures detailed snapshots of a process that helps cancer cells survive — and may point to new treatments.

Over 100 peptide-based drugs are currently available in the US, where they’re used to treat conditions ranging from type-2 diabetes to MS

Spotlight on the recipients of the award